Navigation Links
DuPont Takes Aggressive Actions to Strengthen Competitiveness and Increase Cash Flow
Date:12/4/2008

Company Provides Fourth Quarter 2008 and Full Year 2009 Earnings Guidance

WILMINGTON, Del., Dec. 4 /PRNewswire-FirstCall/ --DuPont, (NYSE: DD) today announced further actions to address current market challenges and strengthen the company's competitiveness in 2009, including continued focus on maximizing cash flow, and provided earnings guidance for the fourth quarter 2008 and the full year 2009.

A steep global decline in construction and motor vehicle sales and consumer spending has resulted in declining industrial production, intensified by inventory reductions across most supply chains. These conditions have precipitated a sharp downturn in demand during the fourth quarter.

"We have taken immediate and aggressive actions to maximize cash flow by reducing cost, working capital and capital expenditures in response to current market challenges," said DuPont Chairman and CEO Charles O. Holliday, Jr. "We will build on our strong financial and market positions and continue prudent financial discipline in navigating through this challenging economic environment. We are providing 2009 earnings guidance and underlying assumptions in our effort to be as transparent as possible with respect to the current and expected impact of the global recession. We are, however, realistic about the potential for further change and we will adjust actions as conditions warrant."

Summary

  • Full-year 2008 free cash flow is expected to be about $1.3 billion, as planned, with working capital improvements offsetting earnings decline. Free cash flow will increase to about $2.5 billion in 2009, reflecting a planned $1 billion net working capital reduction and a 10 to 20 percent reduction in capital spending.
  • DuPont is taking acti
    '/>"/>

SOURCE DuPont
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. DuPont Leaders Brief Investors on Agriculture Businesses
2. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
3. DuPont and Plantic Technologies Announce Starch-Based Bio Materials Collaboration
4. DuPont Named Among Top Biotechnology Employers by Science Magazine
5. Biotechnology Needed to Help Meet Growing Global Needs for Food, Feed, Fuel and Materials, DuPont Chairman & CEO Says at World Food Prize
6. DuPont Joint Venture with Chinese Biotech Firm Strengthens Gene Discovery Research Efforts
7. DuPont Congratulates Growers Planting Pioneer(R) Brand Sorghum Hybrids in Winning Majority of National Categories in Yield Contest
8. DuPont Names Nicholas Fanandakis as Group Vice President - DuPont Applied BioSciences
9. DuPont Chief Science & Technology Officer Offers Perspectives on Science and Global Policymaking at Davos World Economic Forum
10. DuPont and Precision BioSciences Collaborate to Accelerate Crop Product Development
11. Research Confirms Better Oil from New DuPont High Oleic Soybean Trait

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-Asia/ -...d & Drug Administration (SFDA) has approved th...ts oral insulin project,(Nodlin), an innovative in...oval allows Biolaxy to initiate its first phase I ...characteristic of high blood glucose and poor,meta...
(Date:11/24/2009)... The FBI recently approved the Pr...es participating in or generating DNA records for ... Madison, WI USA (PRWEB) -- The FBI recentl...m for use by laboratories participating in, or ge...ystem (NDIS). NDIS currently contains more than se...
(Date:11/24/2009)..., TSX VENTURE: HTL , TORONTO, Nov. 24 /PRN...HTL), formerly Calotto Capital Inc., a leading pro...r the stem cell research and fertility clinic mark...lts for the third quarter ended September 30, 2009...$1.46 million compared with $1.43 million in Q3 20...
(Date:11/24/2009)... , SAN DIEGO, Nov. 24, 2009 /PRNewswire-First...A ) announced today that the company is schedule...th Care Conference on December 1, 2009 at 11:30 a....w York Palace Hotel in New York City. Jack Lief, A...cheduled to provide an overview of the company, in...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3
...ANCOUVER and SAN DIEGO, Jan. 31 /PRNewswire-FirstC...ical-stage developer of drugs for infectious,disea...py arm to its,currently enrolling Phase II viral k...nt-naive patients. The protocol amendment to this ... Review Board (IRB) approvals. The,purpose of this...
...oundation Continues Research Initiatives in Search... for Paralysis, SHORT HILLS, N.J., Jan. 31 The...ch is dedicated to curing spinal cord injury by,fu...y of life for people,living with paralysis through... it has awarded $1,996,745 million to 16 laborator...
...ILLBROOK, N.Y., Jan. 31 Mr. Donald Fresne, Chairm...he company has recently,obtained from Harvard Univ...ts that cover certain technologies related to canc...chnologies, which were developed jointly,by scient...and the,Department of Biological Chemistry and Mol...
Other Biology Technology:MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study 2MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study 3MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study 4MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study 5MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study 6Christopher and Dana Reeve Foundation Awards Nearly $2 Million in Individual Research Grants 2Christopher and Dana Reeve Foundation Awards Nearly $2 Million in Individual Research Grants 3
(Date:11/25/2009)...BER 25, 2009 Soil is the linchpin of the environm...meet. Despite that, many students see soil as "jus... Soil science educators are challenged with the ta...e critical importance of soil in the environment. ...arth science teachers at University of Nebraska-Li...
(Date:11/24/2009)...ears it has been prescribed by traditional healers...ches and stomach pain to fever and flu. , Now for...ty have been able to scientifically prove the pain...se known as Brazilian mint. , Testing this ancien...earcher Graciela Rocha was able to show that when ...
(Date:11/24/2009)...eakened and flabby arteries from collapsing have b...stents are no longer needed -- once the arteries a...ly, doctors had no choice but to leave them in pla...ity,s Department of Biomedical Engineering has dev...rries drugs where they,re needed, then dissolves. ...
Breaking Biology News(10 mins):It's not just dirt! 2Got a pain? -- Have a cup of Brazilian mint 2A coating for life 2Final 12 Month Clinical Data from 5 000 Patients in Worldwide e HEALING Clinical Study Show Good Safety and Efficacy with Real World Use of OrbusNeich 14218 1Final 12 Month Clinical Data from 5 000 Patients in Worldwide e HEALING Clinical Study Show Good Safety and Efficacy with Real World Use of OrbusNeich 14218 2Final 12 Month Clinical Data from 5 000 Patients in Worldwide e HEALING Clinical Study Show Good Safety and Efficacy with Real World Use of OrbusNeich 14218 3Final 12 Month Clinical Data from 5 000 Patients in Worldwide e HEALING Clinical Study Show Good Safety and Efficacy with Real World Use of OrbusNeich 14218 4Natural Alternatives International Inc Announces Fiscal 2009 Q4 and Full Year Results 58089 1Natural Alternatives International Inc Announces Fiscal 2009 Q4 and Full Year Results 58089 2Natural Alternatives International Inc Announces Fiscal 2009 Q4 and Full Year Results 58089 3Natural Alternatives International Inc Announces Fiscal 2009 Q4 and Full Year Results 58089 4Natural Alternatives International Inc Announces Fiscal 2009 Q4 and Full Year Results 58089 5Natural Alternatives International Inc Announces Fiscal 2009 Q4 and Full Year Results 58089 6Natural Alternatives International Inc Announces Fiscal 2009 Q4 and Full Year Results 58089 7Natural Alternatives International Inc Announces Fiscal 2009 Q4 and Full Year Results 58089 8MedCath Names Art Parker Executive Vice President and Chief Financial Officer 58084 1MedCath Names Art Parker Executive Vice President and Chief Financial Officer 58084 2
...r eye diseases and leading causes of blindnessage-...thycan be reversed or even prevented by drugs that...esearchers at the University of Utah School of Med...d in a new study. , Damage from both diseases was...o4, was activated in mice models that simulate age...
...oneers in small RNA research--Victor Ambros, Gary ...recent discoveries at a special half-day symposium...0 p.m., Wednesday, April 16, in the Gore Recital H...nt will be held in their honor, as the 2008 winner...dal in Life Science. , UD,s symposium is part of ...
...nderstand how nitrogen accumulates in large rivers...Walter Dodds looked at small streams flowing close...sas State University, didn,t have to look any fart... Creek at K-State was one of nine small waterways ... nitrogen is removed from streams. With a grant fr...
Other Biology News:Blood vessel protein reverses macular degeneration, diabetic retinopathy in mice 2Blood vessel protein reverses macular degeneration, diabetic retinopathy in mice 3Pioneers in small RNA research to present at UD symposium, April 16 2Pioneers in small RNA research to present at UD symposium, April 16 3Research team finds that microorganisms filter nitrogen from small streams 2
...ptimised for SYBR Green I assays and contain all t...R, with the exception of template and primers. The... active SYBR Green I dye and Thermo-Start DNA Poly...hat enables detection of low copy number targets.,...
... all-in-one rotator/rocker with a multi-action pla... rotating, rocking/shaking, rotating/rocking, rol...mbination of all these actions. The precision-eng... Genie consists of a two-sided, stainless steel pl...
...ion Kit, Plasmid is designed for use with high-yie...No. 3 186 148, 3 186 156, 3 335 461). This kit pro... N-terminal AviTag peptide sequence. The expressed... E. coli biotin protein ligase (BirA, E.C. 6.3.4.1...
... RFC1 Immunogen Recombinant protein correspondin... expressed in E. coli. Reactivity / Specificity ... tested in other species. This antibody recognizes... Replication factor C is a multisubunit, DNA polym...
Biology Products: